Q2 FY2026 · ended Jun 30, 2026 · Revenue $0 · Filed Aug 14, 2026
Nu-Med Plus, Inc. (NUMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $0 and net income of $19,670. As of Jun 30, 2026 it held $5,409 in cash and investments and $0 in total debt.
Revenue
$0
Net income
$19,670
+223.9% vs prior quarter
Operating cash flow
$1,125
+117.6% vs prior quarter
Free cash flow
—
EPS
$0.00
+100.0% vs prior quarter
Dividend per share
None
Shares outstanding
83.55M
+0.0% vs prior quarter
Net cash
$5,409
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NUMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- Port Jefferson, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1543637
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2024 Dec 31, 2024 |
Q3 FY2024 Sep 30, 2024 |
Q1 FY2024 Mar 31, 2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| Operating income | -$22,556 | -$13,151 | -$9,294 | -$17,417 | -$20,579 |
| Net income | $19,670 | -$15,878 | -$10,555 | -$18,677 | -$21,826 |
| Diluted EPS | $0.00 | -$0.00 | -$0.00 | $0.00 | $0.00 |
| Operating cash flow | $1,125 | -$6,377 | -$1,668 | -$2,765 | -$450 |
| Total assets | $12,909 | $7,184 | $9,373 | $6,841 | $9,016 |
| Total liabilities | $280,395 | $294,340 | $224,469 | $211,382 | $177,593 |
| Stockholders' equity | -$267,486 | -$287,156 | -$215,096 | -$204,541 | -$168,577 |
| Cash and investments | $5,409 | $4,284 | — | — | $6,356 |
| Total debt | $0 | $0 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 20, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
|
Aug 25, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 10, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jun 30, 2026 | Jun 26, 2026 |
All 161 Nu-Med Plus, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.